TY - JOUR AU - Kerr, G. S. AU - Hallahan, C. W. AU - Giordano, J. PY - 1994 DA - 1994// TI - Takayasu arteritis JO - Ann Intern Med VL - 120 UR - https://doi.org/10.7326/0003-4819-120-11-199406010-00004 DO - 10.7326/0003-4819-120-11-199406010-00004 ID - Kerr1994 ER - TY - JOUR AU - Schmidt, J. AU - Kermani, T. A. AU - Bacani, A. K. PY - 2013 DA - 2013// TI - Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients JO - Mayo Clin Proc VL - 88 UR - https://doi.org/10.1016/j.mayocp.2013.04.025 DO - 10.1016/j.mayocp.2013.04.025 ID - Schmidt2013 ER - TY - JOUR AU - Schmidt, J. AU - Kermani, T. A. AU - Bacani, A. K. AU - Crowson, C. S. AU - Matteson, E. L. AU - Warrington, K. J. PY - 2012 DA - 2012// TI - Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup JO - Arthritis Care Res (Hoboken) VL - 64 ID - Schmidt2012 ER - TY - JOUR AU - Mekinian, A. AU - Neel, A. AU - Sibilia, J. PY - 2012 DA - 2012// TI - Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study JO - Rheumatology (Oxford) VL - 51 UR - https://doi.org/10.1093/rheumatology/ker380 DO - 10.1093/rheumatology/ker380 ID - Mekinian2012 ER - TY - JOUR AU - Ferfar, Y. AU - Mirault, T. AU - Desbois, A. C. PY - 2016 DA - 2016// TI - Biotherapies in large vessel vasculitis JO - Autoimmun Rev VL - 15 UR - https://doi.org/10.1016/j.autrev.2016.02.012 DO - 10.1016/j.autrev.2016.02.012 ID - Ferfar2016 ER - TY - JOUR AU - Mekinian, A. AU - Comarmond, C. AU - Resche-Rigon, M. PY - 2015 DA - 2015// TI - Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients JO - Circulation VL - 132 UR - https://doi.org/10.1161/CIRCULATIONAHA.114.014321 DO - 10.1161/CIRCULATIONAHA.114.014321 ID - Mekinian2015 ER - TY - JOUR AU - Saadoun, D. AU - Lambert, M. AU - Mirault, T. PY - 2012 DA - 2012// TI - Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience JO - Circulation VL - 125 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.058032 DO - 10.1161/CIRCULATIONAHA.111.058032 ID - Saadoun2012 ER - TY - JOUR AU - Abisror, N. AU - Mekinian, A. AU - Lavigne, C. AU - Vandenhende, M. A. AU - Soussan, M. AU - Fain, O. PY - 2013 DA - 2013// TI - Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review JO - Autoimmun Rev VL - 12 UR - https://doi.org/10.1016/j.autrev.2013.06.019 DO - 10.1016/j.autrev.2013.06.019 ID - Abisror2013 ER - TY - JOUR AU - Samson, M. AU - Espigol-Frigole, G. AU - Terrades-Garcia, N. PY - 2018 DA - 2018// TI - Biological treatments in giant cell arteritis & Takayasu arteritis JO - Eur J Intern Med VL - 50 UR - https://doi.org/10.1016/j.ejim.2017.11.003 DO - 10.1016/j.ejim.2017.11.003 ID - Samson2018 ER - TY - JOUR AU - Canas, C. A. AU - Canas, F. AU - Izquierdo, J. H. PY - 2014 DA - 2014// TI - Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis JO - J Clin Rheumatol VL - 20 UR - https://doi.org/10.1097/RHU.0000000000000098 DO - 10.1097/RHU.0000000000000098 ID - Canas2014 ER - TY - JOUR AU - Loricera, J. AU - Blanco, R. AU - Hernandez, J. L. PY - 2016 DA - 2016// TI - Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review JO - Clin Exp Rheumatol VL - 34 ID - Loricera2016 ER - TY - JOUR AU - Bredemeier, M. AU - Rocha, C. M. AU - Barbosa, M. V. AU - Pitrez, E. H. PY - 2012 DA - 2012// TI - One-year clinical and radiological evolution of a patient with refractory Takayasu’s arteritis under treatment with tocilizumab JO - Clin Exp Rheumatol VL - 30 ID - Bredemeier2012 ER - TY - JOUR AU - Xenitidis, T. AU - Horger, M. AU - Zeh, G. AU - Kanz, L. AU - Henes, J. C. PY - 2013 DA - 2013// TI - Sustained inflammation of the aortic wall despite tocilizumab treatment in two cases of Takayasu arteritis JO - Rheumatology (Oxford) VL - 52 UR - https://doi.org/10.1093/rheumatology/ket107 DO - 10.1093/rheumatology/ket107 ID - Xenitidis2013 ER - TY - STD TI - Nakaoka Y, Isobe M, Takei S, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis. 2019;78:e9. ID - ref14 ER - TY - JOUR AU - Batu, E. D. AU - Sonmez, H. E. AU - Hazirolan, T. AU - Ozaltin, F. AU - Bilginer, Y. AU - Ozen, S. PY - 2017 DA - 2017// TI - Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature JO - Semin Arthritis Rheum VL - 46 UR - https://doi.org/10.1016/j.semarthrit.2016.07.012 DO - 10.1016/j.semarthrit.2016.07.012 ID - Batu2017 ER - TY - STD TI - Decker P, Olivier P, Risse J, Zuily S, Wahl D. Tocilizumab and refractory Takayasu disease: four case reports and systematic review. Autoimmun Rev. 2018;17:353–60. ID - ref16 ER - TY - STD TI - Lee YH, Song GG. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis. Ann Rheum Dis. 2019;78:e9. ID - ref17 ER - TY - JOUR AU - Zhou, J. AU - Chen, Z. AU - Li, J. PY - 2017 DA - 2017// TI - The efficacy of tocilizumab for the treatment of Chinese Takayasu’s arteritis JO - Clin Exp Rheumatol VL - 35 ID - Zhou2017 ER - TY - JOUR AU - Comarmond, C. AU - Biard, L. AU - Lambert, M. PY - 2017 DA - 2017// TI - Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients JO - Circulation VL - 136 UR - https://doi.org/10.1161/CIRCULATIONAHA.116.027094 DO - 10.1161/CIRCULATIONAHA.116.027094 ID - Comarmond2017 ER - TY - JOUR AU - Barra, L. AU - Yang, G. AU - Pagnoux, C. PY - 2018 DA - 2018// TI - Canadian Vasculitis network (CanVasc) non-glucocorticoid drugs for the treatment of Takayasu’s arteritis: a systematic review and meta-analysis JO - Autoimmun Rev VL - 17 UR - https://doi.org/10.1016/j.autrev.2018.01.019 DO - 10.1016/j.autrev.2018.01.019 ID - Barra2018 ER -